Tag: price-prior
-
Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
By Ben Hirschler and Leigh Thomas LONDON/PARIS (Reuters) – French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover fight after the U.S. cancer firm rebuffed its approaches. The decision to target Medivation marks a return to the biotech takeover trail for…
-
Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
By Ben Hirschler and Leigh Thomas LONDON/PARIS (Reuters) – French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover fight after the U.S. cancer firm rebuffed its approaches. The decision to target Medivation marks a return to the biotech takeover trail for…
-
UBS, MPM team up on $471 million cancer fund to speed drug development
(Corrects minimum commitment to $200,000 from $500,000 figure given by UBS on Wednesday) ZURICH (Reuters) – A $471 million UBS venture fund aims to generate annual returns “north of 10 percent” for its European and Asian investors by financing new cancer drugs, helping speed them from the lab to the point where drug companies buy…